Lynch Daniel's Form 4 filing
SpringWorks Therapeutics, Inc.SWTX · filed Feb 12, 2025
- Accession no.
- 0001104659-25-012364
- Filed
- Feb 12, 2025
- Trade date
- Feb 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $9.53M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lynch DanielCIK 0001177082 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Common Stock | SSaleDisposed | −69,766 | $53.23F2 | −$3,713,644.18 | 236,178 | Direct | |
| Feb 10, 2025 | Common Stock | SSaleDisposed | −39,634 | $54.88F3 | −$2,175,113.92 | 196,544 | Direct | |
| Feb 10, 2025 | Common Stock | SSaleDisposed | −65,600 | $55.51F4 | −$3,641,456 | 130,944 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.28 to $55.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.40 to $55.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.